IMMUNOLOGY & COMPUTATIONAL BIOLOGY
Revolutionizing Disease Understanding with AI-Powered Immune Cell Analysis
Our platform leverages single-cell transcriptomics to map the complex inflammation landscape across diverse diseases, transforming circulating immune cells into living biomarkers for precision medicine.
Unlocking Precision Diagnostics & Therapeutic Targets
This AI-driven analysis provides unparalleled insights into inflammatory processes, enabling earlier detection, more accurate classification, and personalized treatment strategies across a spectrum of acute and chronic conditions.
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Our analysis delineates specific gene signatures and regulatory networks driving inflammatory processes in diseases like SLE, RA, and sepsis. We've identified unique upregulation patterns for adhesion molecules, TNF signaling, and antigen presentation, offering novel targets for therapeutic intervention.
We've pinpointed discriminative inflammation-related genes, such as CYBA and IFITM1, whose altered activity in peripheral blood cells serves as powerful biomarkers. These genes exhibit cell-type-specific expression patterns crucial for understanding disease progression and informing precision medicine. For example, CYBA's role in barrier tissue diseases and IFITM1's importance in chronic conditions like COPD and asthma are highlighted, opening avenues for early detection and personalized monitoring.
Leveraging peripheral blood mononuclear cells (PBMCs) as living biomarkers, our interpretable machine learning framework achieves an 87% balanced accuracy in classifying patients across 19 diseases. This approach establishes a robust foundation for universal diagnostic tools, enabling accurate disease identification and stratification even for previously undiagnosed or misdiagnosed cases.
Enterprise Process Flow
| Feature | Traditional Methods | OwnYourAI Platform |
|---|---|---|
| Resolution |
|
|
| Disease Scope |
|
|
| Interpretability |
|
|
| Diagnostic Potential |
|
|
Case Study: Advancing IBD Diagnostics
In Inflammatory Bowel Diseases (IBD) like Crohn's Disease and Ulcerative Colitis, our platform revealed lower levels of unconventional T cells (UTCs) and innate lymphoid cells (ILCs), alongside higher proportions of monocytes and B cells. This fine-grained cellular compositional analysis, validated against previously described alterations, allows for more precise patient stratification and monitoring, guiding targeted therapies beyond conventional diagnostics.
Calculate Your Potential ROI
Estimate the impact of AI-powered precision diagnostics on your operational efficiency and cost savings.
Your Path to AI-Driven Diagnostics
We've streamlined our implementation process to integrate seamlessly with your existing infrastructure, ensuring rapid deployment and measurable impact.
Phase 1: Discovery & Strategy
In-depth analysis of your current diagnostic workflows, data landscape, and key objectives. Collaborative workshop to define custom AI models and integration points.
Phase 2: Platform Integration & Training
Secure integration of our single-cell analysis platform. Initial training on your specific datasets, refining models for optimal performance and interpretability.
Phase 3: Validation & Pilot Deployment
Rigorous validation of AI models using historical and prospective data. Pilot deployment in a controlled environment, demonstrating real-world efficacy and ROI.
Phase 4: Full-Scale Operation & Optimization
Seamless transition to full operational status. Continuous monitoring, model retraining, and iterative optimization to ensure sustained peak performance and evolving insights.
Ready to Transform Your Diagnostics?
Our team of AI and immunology experts is ready to help you unlock the full potential of precision medicine. Book a free consultation today.